AVITA Medical, Inc. (RCEL)

AVITA Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2021
Cash & Equivalents	14.87	14.05	22.12	18.16	55.51	110.75
Short-Term Investments	10.95	21.84	66.94	61.18	29.65	-
Cash & Short-Term Investments	25.82	35.89	89.06	79.34	85.16	110.75
Cash Growth	-62.13%	-59.71%	12.24%	-6.83%	-23.10%	50.39%
Accounts Receivable	12.05	11.84	7.69	3.53	3.43	7.4
Other Receivables	0.1	0.12	0.23	1.18	0.09	0.48
Receivables	12.15	11.96	7.92	4.71	3.51	7.88
Inventory	8.4	7.27	5.6	2.13	2.13	1.65
Prepaid Expenses	1.61	1.88	1.43	0.92	1.12	0.85
Restricted Cash	-	-	-	-	0.2	0.2
Other Current Assets	-	-	-	0.36	0	-
Total Current Assets	47.97	57	104.01	87.46	92.13	121.33
Property, Plant & Equipment	13.25	13.59	4.32	2.05	2.81	2.94
Long-Term Investments	-	-	-	6.93	19.69	-
Other Intangible Assets	5.45	5.57	0.49	0.47	0.44	0.47
Long-Term Deferred Charges	-	-	-	-	0.5	0.61
Other Long-Term Assets	2.89	3.55	2.83	1.36	0.44	0.15
Total Assets	69.56	79.71	111.64	98.26	116.02	125.5
Accounts Payable	8.68	6.29	3.79	3	2.71	3.12
Accrued Expenses	8.84	12.55	8.14	6.7	5.36	3.32
Current Portion of Leases	-	0.9	0.9	0.61	0.72	0.7
Current Unearned Revenue	0.03	0.03	0.03	-	-	-
Other Current Liabilities	5.41	0.39	0.34	0.38	0.36	0.25
Total Current Liabilities	22.96	20.16	13.2	10.69	9.15	7.39
Long-Term Debt	41.46	42.25	39.81	-	-	-
Long-Term Leases	2.61	2.84	1.7	0.31	0.92	0.88
Long-Term Unearned Revenue	0.32	0.32	0.36	0.7	0.95	1.08
Other Long-Term Liabilities	6.78	9.65	7.51	1.83	0.38	0.5
Total Liabilities	74.13	75.21	62.58	13.52	11.39	9.85
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	370.82	367.57	350.04	339.83	332.48	328.89
Retained Earnings	-373.67	-359.81	-297.97	-262.59	-235.92	-221.5
Comprehensive Income & Other	-1.72	-3.26	-3.02	7.5	8.06	8.26
Shareholders' Equity	-4.57	4.5	49.06	84.74	104.62	115.66
Total Liabilities & Equity	69.56	79.71	111.64	98.26	116.02	125.5
Total Debt	44.07	45.99	42.41	0.92	1.64	1.58
Net Cash (Debt)	-18.26	-10.1	46.65	85.35	103.21	109.17
Net Cash Growth	-	-	-45.35%	-17.30%	-5.45%	53.35%
Net Cash Per Share	-0.70	-0.39	1.84	3.41	4.24	4.81
Filing Date Shares Outstanding	26.43	26.36	25.71	25.3	24.93	24.9
Total Common Shares Outstanding	26.43	26.35	25.68	25.21	24.93	24.9
Working Capital	25.01	36.84	90.81	76.77	82.99	113.94
Book Value Per Share	-0.17	0.17	1.91	3.36	4.20	4.65
Tangible Book Value	-10.02	-1.07	48.57	84.28	104.18	115.18
Tangible Book Value Per Share	-0.38	-0.04	1.89	3.34	4.18	4.63
Machinery	6.55	6.2	3.02	1.97	1.88	1.81
Construction In Progress	0.1	0.44	0.09	0.26	0.03	0.05
Leasehold Improvements	4.66	4.61	0.37	0.26	0.24	0.24

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q